Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
MedTech
Embecta shutters insulin patch pump program amid restructuring
Despite winning an FDA green light three months ago for its first wearable insulin system, Embecta is now discontinuing its patch pump program.
Conor Hale
Nov 26, 2024 12:52pm
Medtronic scores FDA clearance for smart insulin pen app
Nov 20, 2024 11:12am
Medtronic sees pulsed field ablation cut into cryo sales
Nov 19, 2024 3:00pm
AI spots high blood pressure, diabetes in slow-motion video
Nov 18, 2024 11:30am
Amgen disappears lung disease program after phase 2 fail
Oct 30, 2024 5:59pm
Dexcom posts mixed-bag earnings report amid Stelo rollout
Oct 25, 2024 1:30pm